Literature DB >> 3292365

Pathologic analysis of liver transplantation for primary biliary cirrhosis.

A J Demetris1, B H Markus, C Esquivel, D H Van Thiel, S Saidman, R Gordon, L Makowka, G D Sysyn, T E Starzl.   

Abstract

A retrospective histopathologic review of all pathologic specimens from 394 adult liver transplant patients was undertaken with clinical correlation to determine if primary biliary cirrhosis has affected the posttransplant course compared to all other indications for liver transplantation and if recurrent primary biliary cirrhosis has occurred after liver transplantation. We also compared the histopathologic features seen in native livers with primary biliary cirrhosis to failed allografts with chronic rejection. One hundred six of the 394 adult patients transplanted during this time (1981 to July, 1986) fulfilled clinicopathologic criteria for a diagnosis of primary biliary cirrhosis. Neither the incidence nor any qualitative pathologic feature of histologically documented acute cellular rejection differentiated subjects transplanted for primary biliary cirrhosis vs. other diseases. No correlation between the titers of antimitochondrial antibody and the presence of posttransplant hepatic dysfunction based on liver enzyme profiles or the development of chronic rejection was seen in patients transplanted for primary biliary cirrhosis. Minor differences noted in the posttransplant course of primary biliary cirrhosis patients as compared to other conditions (higher incidence of chronic rejection as a cause of graft failure) was seen, but this did not significantly affect graft or patient survival. Recurrent primary biliary cirrhosis could not be diagnosed with certainty in any patient. A comparison of failed chronically rejected allografts vs. native hepatectomies obtained from patients with primary biliary cirrhosis revealed the presence of chronic obliterative vasculopathy, centrilobular cholestasis, and lack of granulomas, cirrhosis, cholangiolar proliferation, copper-associated protein deposition and Mallory's hyalin in specimens with chronic rejection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292365      PMCID: PMC2981803          DOI: 10.1002/hep.1840080439

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis. Evidence for different underlying mechanisms and different antigenic determinants as targets.

Authors:  S Vento; C J O'Brien; B M McFarlane; I G McFarlane; A L Eddleston; R Williams
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

2.  Functional characterization of infiltrating T lymphocytes in human hepatic allografts.

Authors:  J J Fung; A Zeevi; T E Starzl; J Demetris; S Iwatsuki; R J Duquesnoy
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

3.  Antibody deposition in liver allografts with chronic rejection.

Authors:  A J Demetris; B H Markus; J Burnham; M Nalesnik; R D Gordon; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

Review 4.  Clinical and prognostic relevance of different mitochondrial antibody profiles in primary biliary cirrhosis (PBC).

Authors:  P A Berg; R Klein
Journal:  Mol Aspects Med       Date:  1985

Review 5.  The PBC-specific antigen.

Authors:  H Baum; C Palmer
Journal:  Mol Aspects Med       Date:  1985

Review 6.  Autoreactivity against biliary tract antigens in primary biliary cirrhosis.

Authors:  I G McFarlane
Journal:  Mol Aspects Med       Date:  1985

Review 7.  The cellular pathology of primary biliary cirrhosis.

Authors:  R N MacSween; A D Burt
Journal:  Mol Aspects Med       Date:  1985

Review 8.  The pathogenesis of primary biliary cirrhosis.

Authors:  O Epstein
Journal:  Mol Aspects Med       Date:  1985

9.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

10.  Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation.

Authors:  E B Haagsma; M Manns; R Klein; J Grond; J R Huizenga; M J Slooff; K H Meyer zum Büschenfelde; P A Berg; C H Gips
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

View more
  11 in total

Review 1.  Liver transplantation. A primer for practicing gastroenterologists, Part I.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

Review 2.  Liver transplantation for primary biliary cirrhosis.

Authors:  A G Tzakis; C Carcassonne; S Todo; L Makowka; T E Starzl
Journal:  Semin Liver Dis       Date:  1989-05       Impact factor: 6.115

Review 3.  Primary biliary cirrhosis and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Intractable Rare Dis Res       Date:  2012-05

4.  Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.

Authors:  A Jain; A J Demetris; R Kashyap; K Blakomer; K Ruppert; A Khan; S Rohal; T E Starzl; J J Fung
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

Review 5.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

Review 6.  The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?

Authors:  A J Demetris; N Murase; C P Delaney; M Woan; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

Review 7.  Cytomegalovirus and chronic allograft rejection in liver transplantation.

Authors:  Liang-Hui Gao; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 8.  Liver transplantation: where it's been and where it's going.

Authors:  D H Van Thiel; L Makowka; T E Starzl
Journal:  Gastroenterol Clin North Am       Date:  1988-03       Impact factor: 3.806

9.  Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.

Authors:  O Pappo; H Ramos; T E Starzl; J J Fung; A J Demetris
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

10.  A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors.

Authors:  S Oguma; S Belle; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.